Pharmaceutical Pre-Submission Meeting: Preparation and Best Practices
A pre-submission meeting in the pharmaceutical sector is an opportunity for the company to talk to the health authority about its regulatory expectations prior to the submission of a marketing authorisation application or other regulatory dossiers. It’s a chance to clarify what’s required in terms of the submission, identify any potential issues, and help shape a more effective regulatory strategy. The meeting is much more effective when the company is properly prepared, ensuring that the discussion is focused and productive.
What Is a Pre-Submission Meeting?
A pre-submission meeting is a formal meeting between the applicant and the regulatory authority prior to the submission of a dossier. It’s an opportunity for the applicant to obtain guidance on clinical, non-clinical, quality, manufacturing, and administrative requirements. The scope of the discussion will vary from authority to authority and from application type to application type, and may include discussions on the data required, study design, dossier format, and route to market.
How to Prepare for a Meeting
Effective preparation starts with clearly identifying what you want to achieve. Companies should follow these steps:
Identify Regulatory Issues: Identify the regulatory issues that require clarification.
Review Regulatory Guidelines: Review the relevant guidelines and submission requirements.
Prepare a Briefing Pack: Prepare a concise briefing pack with relevant product information.
Compile Supporting Data: Compile the supporting clinical, non-clinical, and quality data.
Develop a Meeting Agenda: Develop a structured meeting agenda and a list of anticipated questions.
A well-planned pre-submission meeting provides an opportunity for meaningful discussions and helps applicants obtain relevant regulatory feedback.
Benefits of Pre-Submission Discussions
Early engagement can be highly beneficial in identifying documentation gaps, clarifying regulatory expectations, and avoiding delays during the application assessment. It also improves communication between the applicant and the health authority, enabling applicants to make more informed decisions about their development and submission strategy.
Best Practices for Successful Meetings
Applicants should submit their meeting requests and briefing documents according to the timelines specified by the regulatory authority. Questions should be specific, evidence-based, and prioritised. Relevant subject-matter experts should attend the meeting to address technical aspects of the discussion. Companies should also record meeting outcomes, agreed actions, and responsibilities for follow-up.
How MASUU Global Can Support
MASUU Global provides support to pharmaceutical companies with regulatory strategy, dossier preparation, submission readiness, and regulatory documentation. With a structured approach and the right regulatory expertise, pharmaceutical companies can approach pre-submission meetings with greater clarity and confidence.